Concordance among the three commercially available PD-L1 assays for esophageal squamous cell carcinoma

被引：0
|
作者：
Wang, Lizhen
Guo, Jhe-Cyuan
Chuang, Chien Huai
Cao, Grace
Huang, Stacey
Liu, Jia
Guo, Tony
Wu, Tsung-Che
Li, Shuang
Lin, Jing
King, Hsi-Yu
Cai, Jun
Yang, Wenjun
Liu, Qingyuan
Allen, Simon
Wang, Yifan
Zhang, Jingyu
Hsu, Chih-Hung
机构：
[1] Roche China Holding Ltd, Shanghai, Peoples R China
[2] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
[3] Natl Taiwan Univ, Biomed Pk Hosp, Hsinchu, Taiwan
[4] Genentech South San Francisco, San Francisco, CA USA
[5] Roche, Shanghai, Peoples R China
[6] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4058
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A comparative study of PD-L1 diagnostic assays in squamous cell carcinoma of the head and neck (SCCHN)
    Ratcliffe, M. J.
    Sharpe, A.
    Rebelatto, M.
    Scott, M.
    Barker, C.
    Scorer, P.
    Walker, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] The analysis of T cell subset and the expression of PD-L1, HLA in esophageal squamous cell carcinoma.
    Sudo, Tomoya
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] PD-L1 Immunohistochemical Comparability Multi-Institutional Study in Esophageal Squamous Cell Carcinoma
    Liu, Yueping
    Wang, Xinran
    He, Jiankun
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 486 - 487
  • [34] PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma
    Wang, Qiao
    Feng, Fan
    Wang, Fei
    Liu, Zhen
    Liu, Shushang
    Xu, Guanghui
    Zheng, Gaozan
    Guo, Man
    Lian, Xiao
    Zhang, Hongwei
    JOURNAL OF CANCER, 2018, 9 (12): : 2224 - 2231
  • [35] PD-L1 Immunohistochemical Comparability Multi-Institutional Study in Esophageal Squamous Cell Carcinoma
    Liu, Yueping
    Wang, Xinran
    He, Jiankun
    MODERN PATHOLOGY, 2022, 35 : 486 - 487
  • [36] PD-L1 Immunohistochemical Comparability Multi-Institutional Study in Esophageal Squamous Cell Carcinoma
    Liu, Yueping
    Wang, Xinran
    He, Jiankun
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 486 - 487
  • [37] The concentration of PD-L1 in the peripheral blood could be a useful biomarker for esophageal squamous cell carcinoma
    Shiraishi, Tadashi
    Toyozumi, Takeshi
    Kano, Masayuki
    Murakami, Kentaro
    Sakata, Haruhito
    Sekino, Nobufumi
    Okada, Koichiro
    Ryuzaki, Takahiro
    Kamata, Toshiki
    Matsubara, Hisahiro
    CANCER SCIENCE, 2018, 109 : 415 - 415
  • [38] Correction to: PD-L1 expression in tongue squamous cell carcinoma
    Naoki Akisada
    Kohei Nishimoto
    Soshi Takao
    Yuka Gion
    Hidenori Marunaka
    Tomoyasu Tachibana
    Takuma Makino
    Kentaro Miki
    Yusuke Akagi
    Munechika Tsumura
    Tomohiro Toji
    Tadashi Yoshino
    Kazunori Nishizaki
    Yorihisa Orita
    Yasuharu Sato
    Medical Molecular Morphology, 2021, 54 (1) : 68 - 68
  • [39] PD-L1 and PD-L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma
    Okadome, Kazuo
    Baba, Yoshifumi
    Yasuda-Yoshihara, Noriko
    Nomoto, Daichi
    Yagi, Taisuke
    Toihata, Tasuku
    Ogawa, Katsuhiro
    Sawayama, Hiroshi
    Ishimoto, Takatsugu
    Iwatsuki, Masaaki
    Iwagami, Shiro
    Miyamoto, Yuji
    Yoshida, Naoya
    Watanabe, Masayuki
    Komohara, Yoshihiro
    Baba, Hideo
    CANCER SCIENCE, 2022, 113 (02) : 399 - 410
  • [40] Characterization of PD-L1 Expression in Penile Squamous Cell Carcinoma
    Gellert, Lan
    Shi, Chanjuan
    Giannico, Giovanna A.
    Hameed, Omar
    MODERN PATHOLOGY, 2018, 31 : 342 - 343
12345